Talaromyces atroroseus in HIV and non-HIV patient: A first report from Indonesia.
Med Mycol
; 58(4): 560-563, 2020 Jun 01.
Article
in En
| MEDLINE
| ID: mdl-31504774
ABSTRACT
We performed morphology, molecular study and antifungal susceptibility test on 10 Talaromyces sp. isolates eight clinical isolates (human immunodeficiency virus (HIV) and non-HIV-patient) and two isolates from rats. All strains produced red soluble pigment and microscopically showed Penicillium-like structure in room temperature and yeast-like structure in 37°C. Based on molecular analysis, nine isolates were identified as Talaromyces atroroseus (including the isolates from rats) and one as T. marneffei. Our susceptibility result of T. marneffei supports the use of amphotericin B, itraconazole for talaromycosis marneffei management. Talaromyces atroroseus showed variable MIC to echinocandin, azole derivatives, 5-flucytosine and amphotericin B.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Talaromyces
/
Antifungal Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Med Mycol
Journal subject:
MEDICINA VETERINARIA
/
MICROBIOLOGIA
Year:
2020
Type:
Article